PLC Medical Systems gets expedited review for Heart Laser:
This article was originally published in Clinica
Executive Summary
The US FDA has granted expedited review status to PLC Medical Systems for its PMA application for transmyocardial revascularisation using the Heart Laser. The device will be given priority review because no marketed alternative is available for cardiac patients with medically refractory angina who are not candidates for angioplasty or bypass surgery.